Insulin Receptor Mutation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Insulin Receptor Mutation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05470504

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

Background: Lipodystrophy (LD) syndromes are a group of rare disorders that affect how a person s body can store and use fat tissue. Many people with LDs becom…

United States25 participantsStarted 2023-01-23

Treatment: Pegvisomant

All recent trials (4 shown)

CompletedPhase 2

NCT02457897

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

Background: \- Insulin receptor mutation causes high blood sugars and sometimes diabetes complications. Researchers want to see if thyroid hormone helps. Obje…

United States7 participantsStarted 2015-04-17

Treatment: Liothyronine

UnknownNot Applicable

NCT02023489

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Background: Type 2 diabetes mellitus is a main risk factor for cardiovascular disease and heart failure, in part due to diabetic cardiomyopathy. However, the a…

Austria90 participantsStarted 2013-07

Treatment: 1H/ 13C and 31P Magnetic Resonance Spectroscopy, Meal Tolerance Test

Insulin Receptor Mutation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

All recent trials (4 shown)

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

All recent trials (4 shown)

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation